The managed care sector was sent into a tailspin on Friday as Molina Healthcare (NYSE: MOH) saw its market capitalization evaporate in a historic sell-off. Shares of the Long Beach-based insurer plummeted 28% to $127.16 after the company issued a 2026 earnings forecast that was not just a miss,
Michael Burry says he’s happy with MOH stock, even as Molina Healthcare stock crumbles 25% on disappointing guidance. But are MOH shares really worth buying today?
In a week defined by high-stakes political theater and a brief but disruptive lapse in federal operations, Washington has managed to pull back from the edge of a total collapse—though only partially. On February 3, 2026, a $1.2 trillion appropriations package was signed into law, ending a four-day
Hitting a new 52-week low can be a pivotal moment for any stock.
These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner.
Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.
What a brutal six months it’s been for Humana. The stock has dropped 20.9% and now trades at $195.56, rattling many shareholders. This might have investors contemplating their next move.
Tighter Medicare Advantage payment rates are testing two established health insurers, with CVS Health offering a safer dividend entry at 28% upside and 3% yield while Humana's 36% year-over-year decline creates a riskier but potentially stronger boun...
In a historic display of market resilience and technological optimism, the S&P 500 index officially crossed the 7,000-point threshold on January 28, 2026. This monumental achievement marks a new era for Wall Street, coming just fourteen months after the index first touched 6,000 in late 2024. The
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising
as the industry has posted a 17.4% gain over the past six months, beating the S&P 500 by 7.8 percentage points.
As the first month of 2026 draws to a close, a wave of optimism is sweeping through the equity markets, fueled by a rare alignment of fiscal stimulus, aggressive deregulation, and a structural shift in corporate productivity. Major financial institutions have revised their year-end targets for the S&P 500,
Humana investors may have suffered cardiac arrest yesterday after shares of the health insurer cratered 21% to close below $208 – the lowest level since early 2017.
Wall Street reached a monumental psychological and financial peak on Wednesday as the S&P 500 index briefly eclipsed and then closed near the 7,000-point mark for the first time in history. This breakthrough, occurring on January 28, 2026, represents a staggering 16.6% climb from the 6,000-point
Shares of health insurance company Alignment Healthcare (NASDAQ:ALHC)
jumped 4% in the afternoon session after comments from a Baird analyst suggested a promising outlook for earnings growth, helping the stock rebound from a sharp decline in the previous trading session. The recovery followed a significant drop after the Centers for Medicare & Medicaid Services (CMS) released a preliminary payment proposal for Medicare Advantage that fell short of expectations. The agency proposed a mere 0.09% increase in payment rates, which shocked the industry as analysts had projected growth between 4% and 6%.
